[go: up one dir, main page]

MX9701397A - Emulsiones topicas de ketoconazol. - Google Patents

Emulsiones topicas de ketoconazol.

Info

Publication number
MX9701397A
MX9701397A MX9701397A MX9701397A MX9701397A MX 9701397 A MX9701397 A MX 9701397A MX 9701397 A MX9701397 A MX 9701397A MX 9701397 A MX9701397 A MX 9701397A MX 9701397 A MX9701397 A MX 9701397A
Authority
MX
Mexico
Prior art keywords
emulsions
ketoconazole
topical
topical ketoconazole
antioxidant
Prior art date
Application number
MX9701397A
Other languages
English (en)
Inventor
Marc Karel Jozef Francois
Eric Carolus Leonarda Snoeckx
Original Assignee
Janssen Pharmaceutica Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica Nv filed Critical Janssen Pharmaceutica Nv
Publication of MX9701397A publication Critical patent/MX9701397A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cephalosporin Compounds (AREA)
  • Cosmetics (AREA)

Abstract

La invencion se refiere a emulsiones estables que comprenden ketoconazol que tienen un pH en la escala de 6 a 8, caracterizadas porque las emulsiones carecen de sulfito de sodio como antioxidante; y procedimiento de preparacion de dichas emulsiones.
MX9701397A 1994-09-01 1995-08-25 Emulsiones topicas de ketoconazol. MX9701397A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP94202505 1994-09-01
PCT/EP1995/003366 WO1996006613A1 (en) 1994-09-01 1995-08-25 Topical ketoconazole emulsions

Publications (1)

Publication Number Publication Date
MX9701397A true MX9701397A (es) 1997-05-31

Family

ID=8217156

Family Applications (1)

Application Number Title Priority Date Filing Date
MX9701397A MX9701397A (es) 1994-09-01 1995-08-25 Emulsiones topicas de ketoconazol.

Country Status (19)

Country Link
US (1) US5854246A (es)
EP (1) EP0778771B1 (es)
JP (1) JP3959110B2 (es)
KR (1) KR100381701B1 (es)
CN (1) CN1098074C (es)
AT (1) ATE291917T1 (es)
AU (1) AU698065B2 (es)
CA (1) CA2198240C (es)
DE (1) DE69534120T2 (es)
DK (1) DK0778771T3 (es)
ES (1) ES2240977T3 (es)
IL (1) IL115105A (es)
MX (1) MX9701397A (es)
MY (1) MY115980A (es)
PT (1) PT778771E (es)
SI (1) SI0778771T1 (es)
TW (1) TW460296B (es)
WO (1) WO1996006613A1 (es)
ZA (1) ZA957329B (es)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9604610D0 (sv) * 1996-12-16 1996-12-16 Noviscens Ab Medical composition
WO1998051273A1 (en) * 1997-05-12 1998-11-19 Sage Pharmaceuticals, Inc. Topical spray for burn treatment and anti-infection
JP2001525820A (ja) * 1997-05-14 2001-12-11 ガレン（ケミカルズ）リミティド 局所組成物
AUPO983897A0 (en) 1997-10-17 1997-11-06 Soltec Research Pty Ltd Topical antifungal composition
RU2120305C1 (ru) * 1997-11-27 1998-10-20 Открытое акционерное общество Химико-фармацевтический комбинат "Акрихин" Фармацевтический состав, обладающий противогрибковой активностью, и способ его получения
US5980904A (en) * 1998-11-18 1999-11-09 Amway Corporation Skin whitening composition containing bearberry extract and a reducing agent
US6238683B1 (en) * 1998-12-04 2001-05-29 Johnson & Johnson Consumer Companies, Inc. Anhydrous topical skin preparations
SI3146969T1 (en) * 1999-04-23 2018-08-31 Leo Pharma A/S Ointment for topical treatment of psoriasis
JP2005537244A (ja) * 2002-06-28 2005-12-08 ナステック・ファーマシューティカル・カンパニー・インコーポレーテッド 療法化合物の粘膜搬送を増進させるための、上皮接合部接着分子の生理機能を調節する組成物および方法
IL152486A0 (en) 2002-10-25 2003-05-29 Meir Eini Alcohol-free cosmetic and pharmaceutical foam carrier
US9265725B2 (en) 2002-10-25 2016-02-23 Foamix Pharmaceuticals Ltd. Dicarboxylic acid foamable vehicle and pharmaceutical compositions thereof
US10117812B2 (en) 2002-10-25 2018-11-06 Foamix Pharmaceuticals Ltd. Foamable composition combining a polar solvent and a hydrophobic carrier
US7700076B2 (en) * 2002-10-25 2010-04-20 Foamix, Ltd. Penetrating pharmaceutical foam
US8636982B2 (en) 2007-08-07 2014-01-28 Foamix Ltd. Wax foamable vehicle and pharmaceutical compositions thereof
WO2009072007A2 (en) 2007-12-07 2009-06-11 Foamix Ltd. Carriers, formulations, methods for formulating unstable active agents for external application and uses thereof
MX2011009935A (es) * 2009-03-25 2011-10-06 Sulur Subramaniam Vanangamudi Crema medicinal para dermatitis del pañal y un proceso para hacerla.
US8895542B2 (en) * 2009-04-13 2014-11-25 Vanangamudi Subramaniam Sulur Medicinal fusidic acid cream made using sodium fusidate and incorporating a biopolymer and a process to make it
BG66048B1 (bg) * 2009-04-21 2010-12-30 Емил ЯМАЛИЕВ Състав и метод за получаване на козметичен противопърхутен гел
WO2010125470A2 (en) 2009-04-28 2010-11-04 Foamix Ltd. Foamable vehicle and pharmaceutical compositions comprising aprotic polar solvents and uses thereof
WO2011013009A2 (en) 2009-07-29 2011-02-03 Foamix Ltd. Non surfactant hydro-alcoholic foamable compositions, breakable foams and their uses
WO2011013008A2 (en) 2009-07-29 2011-02-03 Foamix Ltd. Non surface active agent non polymeric agent hydro-alcoholic foamable compositions, breakable foams and their uses
US8871184B2 (en) 2009-10-02 2014-10-28 Foamix Ltd. Topical tetracycline compositions
US9849142B2 (en) 2009-10-02 2017-12-26 Foamix Pharmaceuticals Ltd. Methods for accelerated return of skin integrity and for the treatment of impetigo
CN102018667B (zh) * 2010-10-29 2012-08-08 杭州雷布科技有限公司 一种咪唑类抗真菌皮肤擦拭剂及其制备方法
EP2723452A2 (en) 2011-06-22 2014-04-30 Vyome Biosciences Pvt Ltd Conjugate-based antifungal and antibacterial prodrugs
US8530409B1 (en) * 2012-06-12 2013-09-10 Dipexium Pharmaceuticals LLC Stable pexiganan formulation
MX2015016675A (es) 2013-06-04 2016-07-15 Vyome Biosciences Pvt Ltd Particulas recubiertas y composiciones que comprenden las mismas.
US10398641B2 (en) 2016-09-08 2019-09-03 Foamix Pharmaceuticals Ltd. Compositions and methods for treating rosacea and acne
CN110876756A (zh) * 2019-12-17 2020-03-13 罗香英 用于治疗灰指甲的药膏

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US456935A (en) * 1891-08-04 Axle-cutter
US4144346A (en) * 1977-01-31 1979-03-13 Janssen Pharmaceutica N.V. Novel 1-(1,3-dioxolan-2-ylmethyl)-1H-imidazoles
US4942162A (en) * 1982-03-31 1990-07-17 University Of Tennessee Research Corporation Topical treatment of seborrheic dermatitis with ketoconazole
US4569935A (en) * 1983-03-17 1986-02-11 University Of Tennessee Research Corp. Topical treatment of psoriasis with imidazole antibiotics
JPH0774145B2 (ja) * 1986-12-15 1995-08-09 株式会社資生堂 結晶性薬物含有乳化組成物
US4976953A (en) * 1987-03-06 1990-12-11 The Procter & Gamble Company Skin conditioning/cleansing compositions containing propoxylated glycerol derivatives
US5002974A (en) * 1988-04-04 1991-03-26 Warner-Lambert Co. Anesthetic/skin moisturizing composition and method of preparing same
GB8910069D0 (en) * 1989-05-03 1989-06-21 Janssen Pharmaceutica Nv Method of topically treating acne vulgaris
GB9014221D0 (en) * 1990-06-26 1990-08-15 Janssen Pharmaceutica Nv Method of treating alopecia
US5215839A (en) * 1991-12-23 1993-06-01 Xerox Corporation Method and system for reducing surface reflections from an electrophotographic imaging member
US5456851A (en) * 1994-04-07 1995-10-10 Johnson & Johnson Consumer Products, Inc. Ketoconazole shampoo containing butylated hydroxytoluene or butylated hydroxyanisole

Also Published As

Publication number Publication date
IL115105A (en) 1999-12-22
DK0778771T3 (da) 2005-07-25
DE69534120T2 (de) 2006-01-26
AU3518395A (en) 1996-03-22
TW460296B (en) 2001-10-21
CA2198240C (en) 2007-04-10
CA2198240A1 (en) 1996-03-07
AU698065B2 (en) 1998-10-22
CN1098074C (zh) 2003-01-08
WO1996006613A1 (en) 1996-03-07
MY115980A (en) 2003-10-31
JPH10505346A (ja) 1998-05-26
KR100381701B1 (ko) 2003-09-26
EP0778771A1 (en) 1997-06-18
ES2240977T3 (es) 2005-10-16
US5854246A (en) 1998-12-29
ZA957329B (en) 1997-02-28
PT778771E (pt) 2005-08-31
CN1156407A (zh) 1997-08-06
JP3959110B2 (ja) 2007-08-15
ATE291917T1 (de) 2005-04-15
EP0778771B1 (en) 2005-03-30
SI0778771T1 (en) 2005-10-31
DE69534120D1 (de) 2005-05-04
IL115105A0 (en) 1995-12-08

Similar Documents

Publication Publication Date Title
MY115980A (en) Topical ketoconazole emulsions.
YU28499A (sh) Novi preparati, lekova rastvorenih u vodi, za dobijanje aerosola bez potisnog gasa
MX9601360A (es) Mezcla estabilizante sinergistica.
BG107590A (en) Synthetioc erythropoiesis stimulating proteins
MX9804588A (es) Uso de composiciones que comprenden blanqueador de halogeno para suavidad mejorada a la piel.
GR3027657T3 (en) N-alkylthio polyamine derivatives as radioprotective agents
PL326322A1 (en) Ciral methylphenyloxyazolydinones
CY2440B1 (en) Process improvement in the synthesis of N-A3-(3-cyanopyrazolo A1,5-aUpyrimidin-7-yl)phenylU-N-ethyl-acetamide.
BG101892A (en) Sugar-modified cytostatics
HK56086A (en) Pharmaceutically active succinylated proteins comprising iron
MX9705726A (es) Amidas del acido alcoximinoacetico.
FI20011433L (fi) Menetelmä 2,5,diamino-4,6-diklooripyrimidiinin valmistamiseksi
BG103649A (en) Method for the preparation of eprosartan
MX9602836A (es) MEZCLA QUE CONTIENE UNO O VARIOS ALFA-AMINOACIDOS Y SUS DERIVADOS, O AMBOS, Y UNO O VARIOS CICLOPENTANO- beta-AMINOACIDOS Y SUS DERIVADOS, O AMBOS.
IT1276322B1 (it) Procedimento per la purificazione dell'idrossido di magnesio
AU1913995A (en) Paper opacifier
DE69421195D1 (de) Einstufige herstellung von 4,6 dinitroresorcinol aus resorcinol
MX9603087A (es) Procedimiento para la obtencion de aminocarboniltriazolinonas substituidas.
ATE242763T1 (de) Methoximinophenylessigsäureamide
PH31401A (en) Process for the manufacture of form 1 ranitidine hydrochloride.
MX9603305A (es) Proceso mejorado para la ruptura de emulsiones de aceite.
ZA966347B (en) Process for the preparation of 1,4-butenediol.
ZA991215B (en) Process for the preparation of 1,3-disubstituted 2-nitroguanidines.
MX9602767A (es) Dimaleato de n,n-dietil-8,8-dipropil-2-azaspiro[4,5]decano-2-propanamina.
ZA966542B (en) Process for the preparation of 3,3,5-trichloroglutarimide.